View DNA2 gene homepage

General information
Gene symbol DNA2
Gene name DNA replication helicase/nuclease 2
Chromosome 10
Chromosomal band q21.3-q22.1
Imprinted Unknown
Genomic reference NC_000010.10
Transcript reference NM_001080449.2
Associated with diseases PEOA6
Citation reference(s) -
Curators (3) Lishuang Shen, Xiaowu Gai and Marni J Falk
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created August 13, 2014

Links to other resources
HGNC 2939
Entrez Gene 1763
PubMed articles DNA2
OMIM - Gene 601810
OMIM - Diseases PEOA6 (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6, PEOA6)
GeneCards DNA2
GeneTests DNA2

Active transcripts




NCBI ID     

NCBI Protein ID     

00003305 10 transcript variant 1 NM_001080449.2 NP_001073918.2 0

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2014-2018. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.